US 11001613
TFPI inhibitors and methods of use
granted A61KA61K38/00A61K47/551
Quick answer
US patent 11001613 (TFPI inhibitors and methods of use) held by Takeda Pharmaceutical Company Limited expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61K47/551, A61K47/557, A61K47/60